Massimo Breccia
University of L'Aquila(IT)Policlinico Umberto I(IT)Precision for Medicine (United States)(US)Sapienza University of Rome(IT)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Eosinophilic Disorders and Syndromes
Most-Cited Works
- → Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia(2013)1,585 cited
- → European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia(2016)470 cited
- → Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure(2019)452 cited
- → Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial(2016)387 cited
- → Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group(2010)341 cited
- → Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population